Abstract
Microbial infection is a significant contributing aspect to the development of diseases, posing ongoing challenges in - healthcare. Numerous synthetic antibiotic agents have been used as therapeutic interventions; however, many microorganisms exhibit resistance to these synthetic agents. The rate at which microbes developed resistance to antibiotics has outpaced the discoveries and study of new treatments. The potential of endophytic bacteria to produce bioactive compounds or metabolites that can serve as the basis for developing new antibiotic drugs is promising is promising. This review aims to explore the metabolite potential of endophytic bacteria as a source of antibiotics. Understanding the mechanism and potential of endophytic bacteria offers opportunities for the advancing therapeutic interventions to mitigate the negative effects of various strains of antibiotic-resistant pathogenic bacteria.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
